Related Experiment Video
Updated: Jun 6, 2026
06:11
Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
Published on: May 17, 2024
Gestational diabetes mellitus: taking it to heart
Jessica A Marcinkevage1, K M Venkat Narayan
1Program in Nutrition and Health Sciences, Emory University, Atlanta, GA, USA. jmarcin@emory.edu
Primary Care Diabetes
|November 26, 2010
Summary
Gestational diabetes mellitus (GDM) during pregnancy may increase a woman's risk for future cardiovascular disease (CVD). Research suggests GDM is linked to type 2 diabetes, hypertension, and other CVD risk factors.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Endocrinology
Background:
- Cardiovascular disease (CVD) is a leading cause of death in women globally.
- Gestational diabetes mellitus (GDM), a pregnancy-related glucose intolerance, is increasingly recognized as a potential CVD risk factor.
- Existing research links pre-diabetes to elevated CVD risk, prompting investigation into GDM's role.
Purpose of the Study:
- To review the current evidence associating gestational diabetes mellitus (GDM) with cardiovascular disease (CVD) risk.
- To explore the specific links between GDM and conditions such as type 2 diabetes, hypertension, and atherogenic dyslipidemia.
- To discuss the implications of GDM as a CVD risk factor for future research and clinical practice.
Main Methods:
- Systematic review of existing epidemiological and clinical studies.
- Analysis of data on GDM prevalence and its correlation with subsequent CVD development.
- Synthesis of evidence regarding GDM's impact on intermediate CVD risk markers.
Main Results:
- Evidence suggests a significant association between GDM and an increased risk of developing type 2 diabetes later in life.
- Women with a history of GDM show higher rates of hypertension and atherogenic dyslipidemia.
- Studies indicate a potential link between GDM and an elevated risk of cardiovascular events.
Conclusions:
- Gestational diabetes mellitus (GDM) should be considered a significant risk factor for future cardiovascular disease (CVD) in women.
- Identifying GDM as a CVD risk factor necessitates enhanced screening and preventative strategies for affected women.
- Further rigorous research is crucial to fully elucidate the mechanisms and long-term cardiovascular consequences of GDM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...